Centessa Pharmaceuticals plc Current Cash

Centessa Pharmaceuticals plc (CNTA) currently reports a current cash of $62M as of March 2026. That compares with $110M in the prior-year period — down 40.6% year over year. Use the charts on this page to explore Centessa Pharmaceuticals plc's current cash history and peer comparisons.

Centessa Pharmaceuticals plc's current cash decreased from $110M to $62M — a 40.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Centessa Pharmaceuticals plc reported $62M in current cash as of March 2026. That compares with $110M in the prior-year period — down 40.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $62M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Centessa Pharmaceuticals plc, and consider following CNTA for alerts when major investors trade the stock.

Centessa Pharmaceuticals plc is classified in the Healthcare sector. On current cash, it currently shows $62M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNTA with unrelated industries.